Works matching IS 03407004 AND DT 2015 AND VI 64 AND IP 8

Results: 13

Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 8, p. 941, doi. 10.1007/s00262-015-1700-x

By:

Muto, Masato;
Baghdadi, Muhammad;
Maekawa, Ryuji;
Wada, Haruka;
Seino, Ken-ichiro

Publication type:

Article

CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 8, p. 965, doi. 10.1007/s00262-015-1701-9

By:

Wang, Fei;
Yang, Li;
Gao, Qun;
Huang, Lan;
Wang, Liping;
Wang, Jing;
Wang, Shengdian;
Zhang, Bin;
Zhang, Yi

Publication type:

Article

6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 8, p. 1033, doi. 10.1007/s00262-015-1702-8

By:

Jeanbart, Laura;
Kourtis, Iraklis;
Vlies, André;
Swartz, Melody;
Hubbell, Jeffrey

Publication type:

Article

Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 8, p. 1021, doi. 10.1007/s00262-015-1703-7

By:

McCann, Katy;
Godeseth, Rosemary;
Chudley, Lindsey;
Mander, Ann;
Genova, Gianfranco;
Lloyd-Evans, Paul;
Kerr, Jonathan;
Malykh, Vladimir;
Jenner, Matthew;
Orchard, Kim;
Stevenson, Freda;
Ottensmeier, Christian

Publication type:

Article

Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 8, p. 999, doi. 10.1007/s00262-015-1704-6

By:

Danielli, Riccardo;
Patuzzo, Roberto;
Giacomo, Anna;
Gallino, Gianfranco;
Maurichi, Andrea;
Florio, Annabella;
Cutaia, Ornella;
Lazzeri, Andrea;
Fazio, Carolina;
Miracco, Clelia;
Giovannoni, Leonardo;
Elia, Giuliano;
Neri, Dario;
Maio, Michele;
Santinami, Mario

Publication type:

Article

Cytokine production in patients with papillary thyroid cancer and associated autoimmune Hashimoto thyroiditis.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 8, p. 1011, doi. 10.1007/s00262-015-1705-5

By:

Zivancevic-Simonovic, Snezana;
Mihaljevic, Olgica;
Majstorovic, Ivana;
Popovic, Suzana;
Markovic, Slavica;
Milosevic-Djordjevic, Olivera;
Jovanovic, Zorica;
Mijatovic-Teodorovic, Ljiljana;
Mihajlovic, Dusan;
Colic, Miodrag

Publication type:

Article

Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 8, p. 977, doi. 10.1007/s00262-015-1706-4

By:

Balint, Joseph;
Gabitzsch, Elizabeth;
Rice, Adrian;
Latchman, Yvette;
Xu, Younong;
Messerschmidt, Gerald;
Chaudhry, Arvind;
Morse, Michael;
Jones, Frank

Publication type:

Article

Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 8, p. 951, doi. 10.1007/s00262-015-1694-4

By:

Sarkar, Subhashis;
Gelder, Michel;
Noort, Willy;
Xu, Yunping;
Rouschop, Kasper;
Groen, Richard;
Schouten, Harry;
Tilanus, Marcel;
Germeraad, Wilfred;
Martens, Anton;
Bos, Gerard;
Wieten, Lotte

Publication type:

Article

Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 8, p. 989, doi. 10.1007/s00262-015-1708-2

By:

Binsfeld, Marilène;
Hannon, Muriel;
Otjacques, Eléonore;
Humblet-Baron, Stéphanie;
Baudoux, Etienne;
Beguin, Yves;
Baron, Frédéric;
Caers, Jo

Publication type:

Article

STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 8, p. 1057, doi. 10.1007/s00262-015-1713-5

By:

Wang, Zili;
Celis, Esteban

Publication type:

Article

Second meeting of the Spanish Immunotherapy Group GEIT (Grupo Español de Inmunoterapia), January 16, 2015, in Zaragoza, Spain.

Published in:

2015

By:

Anel, Alberto;
Martínez-Lostao, Luis;
Pardo, Julián

Publication type:

Report

Hepatic myeloid-derived suppressor cells in cancer.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 8, p. 931, doi. 10.1007/s00262-015-1736-y

By:

Medina-Echeverz, José;
Eggert, Tobias;
Han, Miaojun;
Greten, Tim

Publication type:

Article

Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 8, p. 1047, doi. 10.1007/s00262-015-1709-1

By:

Maeda, Yoshinari;
Yoshimura, Kiyoshi;
Matsui, Hiroto;
Shindo, Yoshitaro;
Tamesa, Takao;
Tokumitsu, Yukio;
Hashimoto, Noriaki;
Tokuhisa, Yoshihiro;
Sakamoto, Kazuhiko;
Sakai, Kouhei;
Suehiro, Yutaka;
Hinoda, Yuji;
Tamada, Koji;
Yoshino, Shigefumi;
Hazama, Shoichi;
Oka, Masaaki

Publication type:

Article